About Us
A Vision Born from Experience
New York Cryogen Inc. was founded with a deep understanding of chronic pain not just professionally, but personally. Our journey began in the medical field, assisting neurosurgeons and orthopedic specialists in complex spine surgeries, ensuring precision and patient safety.
Gregory Papageorge, the CEO & Founder of New York Cryogen Inc., possesses a deep understanding of chronic pain, not just professionally, but personally. His journey in the medical field began as a complex spine sales representative, where he provided clinical support and assisted orchestrate the use of his deformity spine systems for neurosurgeons and orthopedic spine surgeons participating in numerous operations assuring the surgical systems were being used correctly.
The Challenge & Breakthrough
In 2016, a life changing spinal surgery resulted in complete paralysis of both arms and months of excruciating pain. Existing cryotherapy Chambers offered no relief. This led to the development of a breakthrough high pressure CO₂ Medical Cryotherapy device engineered for instant and deep pain relief.
Greg underwent an extensive back surgery, which led to a severe bilateral brachial plexus injury. This injury resulted in complete paralysis of both arms for over six months. During the nerve healing process, he experienced excruciating pain. To mitigate this, he underwent more than two dozen surgeries and currently has two neuromodulators implanted, alongside a regimen of pain medications. Unfortunately, these circumstances necessitated his early retirement from the medical devise field.
Engineering the AC-130 VIPER
By amplifying CO2 pressure nearly five fold and integrating advanced skin protection, a revolutionary device was created. This innovation allowed for more effective treatments, shorter sessions, and enhanced comfort.
High pressure cryotherapy for rapid pain relief
Advanced skin protection for maximum comfort
Clinically tested and backed by science
Clinically Approved & Insurance Covered
The AC-130 VIPER is more than just an innovation—it’s a clinically validated breakthrough in pain management. Recognized by the American Medical Association (AMA), this revolutionary cryotherapy treatment has undergone rigorous evaluation, leading to a swift approval process—a rare achievement in the medical field.
With the introduction of CPT billing codes, the AC-130 VIPER became the first cryotherapy solution for pain management to receive official insurance coverage, including Medicare and major private insurance providers. This milestone makes advanced, non invasive pain relief more accessible than ever to patients suffering from chronic and acute pain conditions.
Join the Pain Relief Revolution
The AC-130 VIPER is set for distribution in Spring 2024. Healthcare professionals passionate about cutting edge pain relief solutions are encouraged to connect with us.